Richard L. Vandlen - Department of Molecular Oncology, Genentech, Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 121 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Mechanistic Characterization of the Potency of THIOMAB Antibody-Drug Conjugates Targeting Staphylococcus Aureus and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug Accumulation

Hilda Hernandez-Barry,Josefa Dela Cruz-Chuh, Kimberly K Kajihara,Jyoti Asundi,Richard Vandlen,Donglu Zhang,Wouter L W Hazenbos, Thomas Pillow,Yichin Liu,Cong Wu,Katherine R Kozak,Kelly M Loyet

Bioconjugate chemistryno. 4 (2025): 652-661

Cited0Views0WOSBibtex

MHC2-SCALE Enhances Identification of Immunogenic Neoantigens

Joshua G Gober,Aude-Hélène Capietto, Reyhane Hoshyar, Martine Darwish,Richard Vandlen,Jonathan L Linehan,Lélia Delamarre, Adel M ElSohly

iScienceno. 4 (2025): 112212-112212

Cited0Views0WOSBibtex

Epitope Mapping of Anti-Drug Antibodies to a Clinical Candidate Bispecific Antibody

Arthur J. Schick,Victor Lundin,Justin Low,Kun Peng,Richard Vandlen,Aaron T. Wecksler

mAbs（2022）

Cited8Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn